PLANTS

Language selector

Accessibility tools

Navigation path

Status under Reg. (EC) No 1107/2009 (repealing Directive 91/414/EEC )
Legislation Reg. (EU) 2017/1531 ,
Reg. (EU) No 540/2011 ,
Reg. (EU) No 823/2012
Old Legislation 03/23/EC ,
Reg. (EU) 2016/950 ,
Reg. (EU) 2017/841
Date of approval 01/11/2017 Expiration of approval 31/10/2024
RMS

Co-RMS
FR

IT
Risk Assessment EFSA
Category HB Review Report   Renewal Report 2017
  List of studies relied upon (AIR 3)
  Inclusion 2002
Remarks Renewal of approval: Reg. (EU) 2017/1531
Type Candidate for Substitution (CfS) CfS - criteria two PBT criteria
Authorisation at national level
Authorised in In progress for
AT, BE, BG, CY, CZ, DE, EE, EL, ES, FI, FR, HR, HU, IE, IT, LT, LV, MT, NL, PL, PT, RO, SE, SI, SK, UK
EU - Maximum Residue Levels (Reg. (EC) No 396/2005) (MRLs)
Legislation Annexes
  • Imazamox (Sum of imazamox and its salts, expressed as imazamox)
    MRLs Annex II
Classification Reg. 1272/2008
Aquatic Acute 1 - H400 Aquatic Chronic 1 - H410
Toxicological information
Reference values Source Remark
ADI 3 Reg. (EU) 2017/1531  
ARfD 3 Reg. (EU) 2017/1531  
AOEL 2,25 Reg. (EU) 2017/1531  
Other
 
Legend
  • RMS:Rapporteur Member State
  • Co-RMS:Co-Rapporteur Member State
  • ADI:Acceptable daily intake
  • ARfD:Acute reference dose
  • AOEL:Acceptable operator exposure level